Anaplasmosis in Dogs: Symptoms, Diagnosis, Treatment, and Prevention

🦠
Reviewed by a Licensed Veterinary Doctor (DVM) Internal Medicine and Infectious Disease
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.

Key Takeaways

  • Anaplasmosis in dogs is caused by two distinct species: Anaplasma phagocytophilum, which causes canine granulocytic anaplasmosis (CGA) by invading and replicating inside neutrophils (the primary circulating granulocyte); and Anaplasma platys, which causes canine cyclic thrombocytopenia (CCT) by infecting platelets; A. phagocytophilum is the more clinically significant and more commonly diagnosed species in the United States; both are obligate intracellular organisms belonging to the family Anaplasmataceae (order Rickettsiales), placing them as close relatives of Ehrlichia species; the key cellular target difference is that Ehrlichia canis infects monocytes and macrophages, while A. phagocytophilum infects neutrophils, and A. platys infects platelets, which informs the characteristic laboratory findings of each disease.
  • Anaplasma phagocytophilum is transmitted primarily by Ixodes scapularis (the black-legged tick or deer tick) in the eastern and central United States and by Ixodes pacificus (the western black-legged tick) in the western United States; the geographic distribution of CGA therefore closely mirrors the distribution of Lyme disease (caused by Borrelia burgdorferi), because both pathogens share the same Ixodes tick vectors; this geographic overlap means that dogs in high-risk Lyme disease areas are also at elevated risk for anaplasmosis, and co-infection with both pathogens in the same tick bite (or sequential exposure) is clinically documented and epidemiologically significant; transmission of A. phagocytophilum requires tick attachment for approximately 24 to 48 hours, similar to the transmission requirement for Borrelia burgdorferi, reinforcing the importance of daily tick checks and prompt tick removal.
  • Unlike Rocky Mountain spotted fever (Rickettsia rickettsii), anaplasmosis IS detectable by the SNAP 4Dx Plus in-clinic test; the SNAP 4Dx Plus detects antibodies to both Anaplasma phagocytophilum and Anaplasma platys using antigen from A. phagocytophilum; a positive SNAP result for Anaplasma indicates that the dog has been exposed to Anaplasma and has mounted an antibody response, but it does not by itself confirm that the current illness is caused by active anaplasmosis (a positive result can reflect past resolved exposure); conversely, a dog in the very early acute phase of anaplasmosis (first 4 to 7 days before seroconversion) may test SNAP-negative despite active infection; clinical judgment based on the full picture (signs, tick exposure, CBC findings, geographic location, season) must guide the treatment decision rather than SNAP result alone.
  • The hallmark laboratory finding of Anaplasma phagocytophilum infection is thrombocytopenia (low platelet count), which reflects platelet consumption and immune-mediated platelet destruction triggered by the systemic inflammatory response to infection; thrombocytopenia is present in approximately 70 to 90 percent of confirmed CGA cases and is typically moderate (platelet counts of 50,000 to 150,000 per microliter); a mild to moderate non-regenerative anemia is also common; the most pathognomonic finding (when present) is morulae: intracytoplasmic inclusion bodies visible inside neutrophils on a blood smear, representing colonies of A. phagocytophilum replicating within membrane-bound vacuoles called morulae (from the Latin word for mulberry, which describes their appearance); morulae are found in approximately 4 to 20 percent of confirmed CGA cases on routine blood smear examination, so a negative blood smear does not exclude the diagnosis, but a positive smear with morulae in neutrophils is highly specific for granulocytic anaplasmosis.
  • Doxycycline is the treatment of choice for both Anaplasma phagocytophilum and Anaplasma platys infections in dogs; the standard protocol is 10 mg/kg once daily (or 5 mg/kg twice daily) for 28 days; the 28-day course mirrors the Ehrlichia treatment duration and is used because Anaplasma can establish a subclinical infection that persists in the bone marrow and may relapse if treatment is stopped too early; most dogs with uncomplicated CGA show dramatic clinical improvement within 24 to 48 hours of starting doxycycline, which is itself a useful diagnostic clue (a rapid doxycycline response in a dog with thrombocytopenia, fever, and tick exposure history strongly supports a rickettsial tick-borne disease diagnosis even before confirmatory testing returns); failure to improve within 48 to 72 hours should prompt reassessment for a co-infecting pathogen or an alternative diagnosis.
  • Because Anaplasma phagocytophilum and Borrelia burgdorferi (the Lyme disease bacterium) share the same Ixodes tick vectors and the same geographic distribution, co-infection of a single dog with both pathogens is a clinically relevant possibility in endemic areas; dogs diagnosed with anaplasmosis should be evaluated for concurrent Lyme disease and vice versa; the SNAP 4Dx Plus conveniently detects both Anaplasma antibodies and Borrelia C6 antibody in the same test; a dog with co-infection may require prolonged antibiotic treatment and has a higher risk of proteinuric nephropathy from Lyme nephritis occurring alongside the thrombocytopenic syndrome of anaplasmosis; tick prevention with an isoxazoline or effective acaricide product (NexGard, Simparica, Bravecto, Credelio) is the most effective single intervention for reducing the risk of both anaplasmosis and Lyme disease simultaneously, since both require the same Ixodes tick for transmission.

The 5-year-old Labrador Retriever mix had been lethargic and off his food for two days when his owner noticed him limping on his right front leg. He had been hiking in Connecticut three weeks earlier. His temperature on presentation was 104.8 degrees Fahrenheit. He resisted palpation of multiple joints, wincing when his elbows and stifles were manipulated. The SNAP 4Dx Plus returned positive for Anaplasma and negative for Lyme, heartworm, and Ehrlichia. The CBC showed platelets of 74,000 per microliter with a mild non-regenerative anemia. The blood smear was reviewed carefully: the technician identified small purple granular inclusions inside three neutrophils that were consistent with morulae. The attending veterinarian started doxycycline 10 mg/kg once daily and confirmed the polyarthritis with joint fluid analysis, which revealed a non-septic, highly cellular inflammatory effusion dominated by neutrophils with no bacteria, consistent with immune-mediated arthropathy secondary to anaplasmosis. By day 2 the dog was eating again. By day 5 he was bearing full weight on all four limbs. The 28-day doxycycline course was completed and the CBC at recheck showed complete resolution of thrombocytopenia.

Two Species, Different Target Cells

Anaplasmosis in dogs is not a single disease but a clinical syndrome caused by two biologically distinct Anaplasma species that share the genus name but differ in their cellular targets, tick vectors, geographic distribution, and clinical presentations.

FeatureAnaplasma phagocytophilum (CGA)Anaplasma platys (CCT)
Target cellNeutrophils (granulocytes)Platelets (thrombocytes)
Disease nameCanine granulocytic anaplasmosis (CGA)Canine cyclic thrombocytopenia (CCT)
Primary tick vectorsIxodes scapularis (eastern/central US); Ixodes pacificus (western US)Rhipicephalus sanguineus (brown dog tick); possibly Dermacentor variabilis
Geographic distributionMirrors Lyme disease distribution: northeastern US, upper Midwest, Pacific Coast, some southeastern statesSoutheastern and Gulf Coast US; Mediterranean Europe; tropical and subtropical regions worldwide
Morulae locationIntracytoplasmic inclusions in neutrophils on blood smearIntracytoplasmic inclusions in platelets on blood smear
Cyclic patternNo defined cyclic pattern; acute illnessCyclic thrombocytopenia every 10 to 14 days; bacteremia and platelet drop recur cyclically
Clinical severityModerate to severe acute illness; significant fever, lameness, thrombocytopenia commonOften subclinical or mild; severe disease less common than with A. phagocytophilum
SNAP 4Dx Plus detectionYes (directly detected)Yes (cross-reactive antigen detection)

Anaplasma phagocytophilum: Pathomechanism and Clinical Disease

After A. phagocytophilum enters the bloodstream via tick saliva, it is taken up by circulating neutrophils through a receptor-mediated endocytic process; once inside the neutrophil, it replicates within a membrane-bound vacuole (the morula) and actively subverts the neutrophil’s antimicrobial functions; A. phagocytophilum specifically inhibits the neutrophil oxidative burst (superoxide production) and delays neutrophil apoptosis (programmed cell death), allowing it to use the neutrophil as a protected replication environment for several days before the cell lyses and releases new organisms to infect additional neutrophils.

The clinical disease results from both direct cellular injury and the excessive host inflammatory response to infection:

  • Fever: systemic inflammatory response drives temperature to 103 to 106 degrees Fahrenheit; onset is typically acute (1 to 2 days) and fever is often the first recognized sign
  • Thrombocytopenia: platelet destruction and sequestration driven by immune activation; the mechanism is primarily immune-mediated (platelet-associated IgM and IgG increase during infection) rather than direct platelet infection; counts typically fall to 50,000 to 150,000 per microliter in acute CGA
  • Polyarthritis: joint inflammation is a clinically distinctive feature of CGA that distinguishes it from Ehrlichia canis infection, which does not typically cause joint disease; the arthritis is immune-mediated (synovial fluid shows neutrophilic inflammation without bacteria), not due to direct joint infection; it produces acute-onset lameness, joint swelling, and stiffness that shifts between limbs
  • Lethargy and anorexia: cytokine-driven constitutional signs are prominent and often the chief complaint; affected dogs may be profoundly lethargic, reluctant to move, and completely anorectic
  • Vomiting and diarrhea: GI signs occur in a subset of dogs, likely from mesenteric vasculitis and systemic inflammatory cytokine effects
  • Leukopenia: paradoxically, despite infecting neutrophils, CGA often produces a mild leukopenia (low total white blood cell count) early in infection from bone marrow suppression and accelerated cell death; this shifts to leukocytosis as the immune response escalates

Diagnosis

SNAP 4Dx Plus

The SNAP 4Dx Plus detects IgG antibodies to Anaplasma phagocytophilum using recombinant antigen; because A. platys shares cross-reactive antigens, positive results for Anaplasma on the SNAP 4Dx Plus can indicate exposure to either species. A positive SNAP Anaplasma result means:

  • The dog has been exposed to Anaplasma and has seroconverted (mounted an antibody response)
  • This could reflect active current infection, recent past infection (antibodies persist for months to over a year after treatment), or subclinical exposure that never caused illness
  • A positive result in a dog with compatible clinical signs (fever, thrombocytopenia, lameness) supports active anaplasmosis and is sufficient to begin doxycycline treatment
  • A positive result alone in an asymptomatic dog requires clinical context; healthy dogs with positive Anaplasma titers and no clinical signs do not uniformly require treatment, though this remains an area of veterinary debate

A negative SNAP result does not exclude early acute anaplasmosis; seroconversion typically occurs 4 to 7 days after tick transmission, so a dog infected within the prior week may be SNAP-negative despite active infection. In a clinically ill dog with tick exposure and thrombocytopenia, empirical doxycycline is appropriate even with a negative SNAP.

Blood Smear Evaluation

Morulae (intracytoplasmic inclusion bodies within neutrophils) are the most specific finding for A. phagocytophilum but are present in only 4 to 20 percent of confirmed cases; they are most likely to be found in the first 4 to 7 days of acute infection, before antibody titers rise and before treatment is initiated; morulae should be specifically sought by examining a fresh blood smear made from EDTA-anticoagulated whole blood (not a stored sample) at 1,000x magnification with oil immersion; they appear as small, dark purple, round to ovoid granular clusters within the neutrophil cytoplasm; a positive morulae finding in a clinically compatible dog is sufficient to begin treatment without waiting for additional testing.

IFA Serology (Reference Laboratory)

Indirect immunofluorescence antibody (IFA) testing for A. phagocytophilum measures the actual IgG titer and is more quantitative than the in-clinic SNAP; a fourfold rise in titer between an acute-phase sample (at presentation) and a convalescent-phase sample (2 to 4 weeks later) is the gold standard confirmation; a single titer above 1:80 to 1:256 (laboratory-dependent threshold) is considered supportive of recent or active exposure; IFA serology is primarily useful for retrospective confirmation, documentation, and distinguishing current from past infection in equivocal cases.

PCR Testing

PCR of whole blood (EDTA tube) detects A. phagocytophilum DNA and is most sensitive during the early acute bacteremic phase, before antibiotic treatment is initiated; PCR is particularly useful for confirming active infection in a SNAP-positive dog with nonspecific signs where the clinical picture is not clear-cut; sensitivity declines rapidly after doxycycline is started, so samples should be collected before treatment if at all possible; PCR is available through most state veterinary diagnostic laboratories and commercial reference laboratories; combined PCR and IFA panel testing is available from IDEXX and Antech for comprehensive tick-borne disease evaluation.

CBC and Chemistry Panel

Laboratory findings that support anaplasmosis:

  • Thrombocytopenia: platelet count below 150,000 per microliter in approximately 70 to 90 percent of CGA cases; severe thrombocytopenia (below 20,000 per microliter) with spontaneous hemorrhage is uncommon in CGA but can occur
  • Non-regenerative anemia: mild to moderate anemia in approximately 50 percent of cases; hematocrit typically 28 to 38 percent (reference range approximately 37 to 55 percent)
  • Leukopenia (early) then leukocytosis (later): a mild total WBC count decrease in the first few days of illness; as the immune response escalates a left-shifted leukocytosis (elevated neutrophils with band forms) develops
  • Elevated liver enzymes: ALT and ALP elevations in approximately 30 to 50 percent of cases; typically mild (less than three times the upper limit of normal)
  • Hypoalbuminemia: low albumin in some cases, reflecting systemic inflammation and protein loss; less marked than in chronic ehrlichiosis
  • Normal to low sodium: mild hyponatremia can occur but is less distinctive than in RMSF

Treatment

Doxycycline Protocol

Doxycycline at 10 mg/kg orally once daily for 28 days is the standard of care for both A. phagocytophilum and A. platys infections; the 28-day duration is used because shorter courses have been associated with relapse in some dogs, and Anaplasma (like Ehrlichia) can persist subclinically in bone marrow cells; most dogs with uncomplicated CGA show dramatic improvement within 24 to 48 hours of starting doxycycline, and the clinical response to doxycycline in a dog with thrombocytopenia and fever after tick exposure is itself a strong diagnostic indicator; doxycycline should be given with a small amount of food to minimize gastrointestinal upset and esophageal irritation (esophagitis and esophageal stricture have been reported in dogs given doxycycline tablets without food or water); if a dog vomits the tablet, it should be re-administered; the doxycycline capsule or tablet formulation is preferred over suspension in dogs because the suspension contains a citric acid vehicle that can cause esophageal damage.

Supportive Care

Most dogs with uncomplicated CGA recover fully with outpatient doxycycline treatment and do not require hospitalization; dogs with severe thrombocytopenia (platelet count below 20,000 per microliter) with clinical bleeding signs (epistaxis, melena, petechiae) may require:

  • Hospitalization with close monitoring for hemorrhagic complications
  • Fresh whole blood or platelet-rich plasma transfusion for active life-threatening hemorrhage
  • Restricted physical activity to reduce hemorrhage risk while thrombocytopenia is severe
  • Short-term corticosteroid therapy (prednisone 1 to 2 mg/kg once daily) for dogs with severe immune-mediated thrombocytopenia (platelet count below 10,000 to 20,000 per microliter) unresponsive to doxycycline alone, after ruling out concurrent sepsis; this is used judiciously because corticosteroids can suppress the immune response needed to eliminate the organism

Monitoring After Treatment

A follow-up CBC 2 to 4 weeks after completing doxycycline is recommended to confirm platelet count normalization; thrombocytopenia should resolve within 2 to 4 weeks of treatment in uncomplicated cases; persistent thrombocytopenia after treatment completion raises concern for co-infection (particularly Ehrlichia canis, which can cause prolonged bone marrow suppression), inadequate treatment course, immune-mediated thrombocytopenia that has become self-perpetuating, or concurrent immune-mediated polyarthritis that requires additional treatment; SNAP 4Dx Plus retesting after treatment is NOT useful for confirming cure, because Anaplasma antibodies (detected by the SNAP) persist for months to over a year after successful treatment; a positive SNAP at recheck does not indicate treatment failure or active re-infection.

Anaplasmosis vs. Ehrlichiosis: A Comparative Overview

FeatureAnaplasma phagocytophilum (CGA)Ehrlichia canis (CME)
Organism familyAnaplasmataceaeAnaplasmataceae
Target cellNeutrophils (granulocytes)Monocytes and macrophages
Primary tick vectorIxodes scapularis, Ixodes pacificusRhipicephalus sanguineus (brown dog tick)
Geographic distributionMirrors Lyme disease: northeastern and upper Midwest US, Pacific CoastNationwide; highest prevalence in southeastern and south-central US
SNAP 4Dx PlusYes (detects both A. phagocytophilum and A. platys)Yes (detects E. canis and E. ewingii)
PolyarthritisCommon and clinically distinctiveUncommon (polyarthritis more characteristic of Anaplasma)
Morulae locationNeutrophilsMonocytes
Disease phasesAcute; subclinical phase less prominent than EhrlichiaAcute, subclinical, chronic (chronic phase can be life-threatening)
Chronic severe diseaseLess common; most dogs recover with treatmentChronic phase with aplastic pancytopenia and high mortality risk
Doxycycline duration28 days28 days

Geographic Distribution and Tick Vectors

State/RegionPrimary VectorRisk LevelNotes
Northeastern US (Connecticut, New York, New Jersey, Massachusetts, Pennsylvania, Rhode Island, Maryland)Ixodes scapularisHigh to very highHighest SNAP-positive rates nationally; mirrors Lyme disease hyperendemic zone; year-round tick activity with peak in spring and fall
Upper Midwest (Minnesota, Wisconsin, Michigan, Iowa)Ixodes scapularisHighRapidly expanding Ixodes scapularis population; significant case numbers reported annually; wooded lake country habitat supports high tick density
Pacific Coast (California, Oregon, Washington)Ixodes pacificusModerate to highWestern black-legged tick activity concentrated in coastal and foothill woodland; chaparral and oak woodland habitats particularly high risk; nymphal ticks most active in spring
Southeastern and Gulf Coast USRhipicephalus sanguineus (for A. platys)Moderate (primarily A. platys)A. phagocytophilum less common; A. platys (cyclic thrombocytopenia) more prevalent; often co-diagnosed with Ehrlichia canis given shared brown dog tick vector
Rocky Mountain and Great PlainsIxodes scapularis (expanding range)Low to moderate; increasingRange expansion of Ixodes scapularis is gradually increasing CGA risk in previously low-risk areas; surveillance data updated annually by CDC

US Cost Overview for Anaplasmosis

ServiceTypical US Cost
Veterinary examination$60 to $150
SNAP 4Dx Plus (in-clinic, tests Anaplasma, Ehrlichia, Lyme, heartworm)$50 to $90
Complete blood count$80 to $150
Chemistry panel$80 to $160
Blood smear review for morulae$40 to $80 (or included in CBC)
IFA serology for A. phagocytophilum (reference lab, single titer)$60 to $120
PCR for Anaplasma phagocytophilum (reference lab)$60 to $120
Tick-borne disease PCR panel (Anaplasma + Ehrlichia + Lyme)$120 to $250
Doxycycline (28-day course, 30 kg dog)$30 to $80
Follow-up CBC at 2 to 4 weeks$80 to $150
Hospitalization with IV fluids (per day, severe cases)$500 to $2,000
Monthly isoxazoline tick prevention (large dog)$20 to $50 per month

Age-Specific Considerations

Puppies (Under 12 Months)

  • Puppies are susceptible to anaplasmosis from their first tick exposure and can develop significant thrombocytopenia and systemic illness; a puppy with acute fever, lethargy, and thrombocytopenia in a tick-endemic area during spring or fall should be evaluated for anaplasmosis promptly; the presenting signs (fever, joint pain, reluctance to move) in a puppy can be mistaken for parvovirus, bacterial sepsis, or developmental bone disease, so tick-borne disease must be included in the differential diagnosis for any febrile thrombocytopenic puppy in an endemic area, particularly when the SNAP 4Dx Plus or history supports tick exposure
  • Doxycycline is the appropriate treatment for anaplasmosis in puppies; concerns about doxycycline causing dental discoloration in very young animals have been raised by extrapolation from human pediatric data (where extended doxycycline courses were associated with tetracycline-class tooth staining), but a 28-day doxycycline course for anaplasmosis in a puppy is generally considered acceptable given the severity of untreated tick-borne disease; veterinarians managing puppies under 4 to 6 months of age with anaplasmosis may discuss the dental risk in context with the owner, but no safe alternative to doxycycline exists for treating Anaplasma, and withholding treatment is far more dangerous than the theoretical tooth staining risk
  • Year-round tick prevention is appropriate for puppies living in or visiting Ixodes-endemic areas; isoxazoline products such as NexGard (minimum 8 weeks and 4 pounds) and Simparica (minimum 8 weeks and 2.8 pounds) are approved for use in young puppies and provide effective protection against Ixodes scapularis; because CGA and Lyme disease share the same tick vector, consistent isoxazoline use during puppyhood provides dual protection against both diseases simultaneously

Adult Dogs (1 to 8 Years)

  • Adult dogs represent the majority of clinical anaplasmosis cases; active adult dogs with outdoor exposure in northeastern and upper Midwest endemic areas during spring (April through June) and fall (September through November) face the highest risk of Ixodes scapularis tick exposure; adult dogs on consistent, year-round isoxazoline tick prevention who are still diagnosed with CGA represent either a product gap (late administration, missed dose, product applied in suboptimal conditions such as right before bathing) or a very rapid transmission event from a tick already present when the product was applied; the diagnosis of CGA in a dog on tick prevention does not mean the product is ineffective overall, only that no product achieves 100 percent efficacy against every exposure
  • The polyarthritis of CGA in adult dogs can closely resemble immune-mediated polyarthritis (IMPA) of other causes, and the treatment is very different: doxycycline for anaplasmosis versus immunosuppressive corticosteroids for primary IMPA; a dog presenting with acute-onset shifting leg lameness, joint swelling, and fever should have anaplasmosis (and Lyme disease) excluded before immunosuppressive treatment is initiated; starting corticosteroids in a dog with undiagnosed anaplasmosis may temporarily suppress the fever and lameness while allowing the organism to continue replicating, delaying correct diagnosis and treatment; always run a SNAP 4Dx Plus before prescribing corticosteroids for suspected polyarthritis in dogs from tick-endemic areas
  • Dogs with a prior anaplasmosis diagnosis who are re-exposed and SNAP-positive at annual wellness testing present a management challenge: persistent antibody titers from prior infection mean that a positive SNAP at annual recheck does not confirm current active infection; a complete CBC is the most useful additional test; if the platelet count is normal and the dog is clinically well, the positive SNAP likely reflects residual antibody from prior exposure; if thrombocytopenia or other abnormalities are present, retreatment is appropriate

Senior Dogs (9 Years and Older)

  • Senior dogs with CGA are at elevated risk for complications because age-related decline in immune function (immunosenescence) may reduce the speed and strength of the immune response to Anaplasma, and concurrent chronic diseases common in older dogs (immune-mediated thrombocytopenia, chronic liver disease, renal disease, osteoarthritis) can complicate both the presentation and the management; a senior dog with pre-existing immune-mediated thrombocytopenia on long-term corticosteroids who acquires anaplasmosis presents a complex clinical picture where both the tick-borne disease and the underlying immune dysregulation are driving the platelet count down simultaneously; tick-borne disease must be considered and ruled out before attributing thrombocytopenia relapse solely to the underlying immune condition
  • The polyarthritis of CGA in older dogs can be attributed to osteoarthritis or age-related joint degeneration, causing diagnostic delay; the key distinguishing features are: CGA polyarthritis has an acute onset (days) rather than a progressive onset over months to years, involves multiple joints simultaneously (bilateral stifles, elbows, and carpi are commonly affected), and is accompanied by fever and thrombocytopenia; radiographs of affected joints in CGA typically show soft tissue swelling without bony changes, in contrast to osteoarthritis which shows subchondral sclerosis, osteophyte formation, and joint space narrowing; joint fluid analysis showing neutrophilic inflammation without infection is consistent with CGA polyarthropathy
  • Senior dogs completing a 28-day doxycycline course for anaplasmosis should have a recheck CBC and chemistry panel 2 to 4 weeks after completing treatment; platelet count normalization confirms effective treatment; persistent thrombocytopenia beyond 4 weeks after treatment should prompt investigation for concurrent Ehrlichia infection (which can cause prolonged bone marrow suppression), primary immune-mediated thrombocytopenia that has been unmasked or triggered by the infection, or another underlying cause of thrombocytopenia such as splenic disease or disseminated neoplasia; bone marrow evaluation is indicated for senior dogs with persistent unexplained thrombocytopenia after a full tick-borne disease treatment course

Myths and Facts About Anaplasmosis in Dogs

Myth

My dog tested positive for Anaplasma on the SNAP 4Dx Plus at the annual wellness exam but has no symptoms, so there is nothing to worry about and no follow-up is needed.

Fact

A positive SNAP Anaplasma result in an asymptomatic dog at annual wellness testing requires follow-up evaluation, not dismissal. Run a CBC to check the platelet count. Subclinical thrombocytopenia (platelet count below normal without overt bleeding signs) is common in dogs with active anaplasmosis. An asymptomatic dog with thrombocytopenia and a positive SNAP likely has active infection and benefits from doxycycline treatment. A dog with a normal platelet count and no symptoms likely has residual antibody from past resolved exposure and may not require treatment, but this decision should be made by a veterinarian after CBC review.

Myth

A positive SNAP 4Dx Plus Anaplasma result after completing 28 days of doxycycline means the treatment failed and the dog is still infected.

Fact

A positive Anaplasma SNAP result after treatment does NOT indicate treatment failure. Antibodies to Anaplasma persist for months to over a year after successful doxycycline treatment and a positive SNAP merely detects those residual antibodies. The correct test to assess treatment success is a follow-up CBC to confirm platelet count normalization. Retreating a dog with a normal platelet count and no clinical signs based solely on a persistently positive SNAP is not supported by clinical evidence and is unnecessary.

Myth

Anaplasmosis and Lyme disease are two completely different diseases that require separate prevention strategies.

Fact

Anaplasmosis (caused by Anaplasma phagocytophilum) and Lyme disease (caused by Borrelia burgdorferi) are transmitted by the same tick species, Ixodes scapularis in the eastern US and Ixodes pacificus in the western US, and share essentially the same geographic distribution. Tick prevention with an isoxazoline product that kills or repels Ixodes ticks simultaneously reduces the risk of both diseases. A dog’s protection against one is largely protection against the other. They are transmitted by the same tick bite, and co-infection of a single dog with both pathogens is documented and clinically relevant.

Red Flags: Signs Requiring Same-Day Veterinary Evaluation

  • Acute-onset high fever (above 103.5 to 104 degrees Fahrenheit) combined with reluctance to move, joint swelling, or shifting leg lameness in a dog from a tick-endemic area during spring or fall: this constellation is highly suggestive of anaplasmosis and warrants same-day evaluation including SNAP 4Dx Plus and CBC; starting doxycycline empirically the same day is appropriate in a dog with these signs and tick exposure history, without waiting for test results
  • Any visible bleeding signs in a dog known or suspected to have anaplasmosis: nosebleed (epistaxis), blood in vomit or stool (hematemesis or melena), blood in urine (hematuria), petechiae or ecchymoses on the skin or gums, or prolonged bleeding from minor wounds; these signs indicate severe thrombocytopenia (platelet count likely below 20,000 per microliter) and require emergency veterinary evaluation for potential transfusion and hospitalization
  • A dog with known anaplasmosis on doxycycline that is not improving or is worsening after 48 to 72 hours of treatment: reassess for a co-infecting pathogen (Ehrlichia, Babesia, Lyme), verify that doxycycline is being administered at the correct dose and without food that significantly reduces absorption (high-fat meals can reduce doxycycline bioavailability), and reconsider whether the primary diagnosis is correct; Babesia in particular requires imidocarb dipropionate or atovaquone/azithromycin and does not respond to doxycycline
  • Neurological signs (ataxia, seizures, altered mentation) in a dog with tick exposure and thrombocytopenia: while neurological signs are less common in anaplasmosis than in RMSF, they can occur and represent severe disease; consider also whether concurrent Lyme neuroborreliosis may be contributing in a co-infected dog from an endemic area
  • Profound lethargy to the point of complete collapse, inability to stand, or loss of consciousness in a febrile thrombocytopenic dog: these signs indicate potentially life-threatening systemic inflammation and require emergency evaluation; the dog should be transported without delay, minimizing physical exertion to reduce hemorrhage risk in the setting of severe thrombocytopenia

Frequently Asked Questions About Anaplasmosis in Dogs

What is anaplasmosis in dogs?

Anaplasmosis in dogs is a tick-borne infection caused by Anaplasma phagocytophilum (which infects neutrophils, causing canine granulocytic anaplasmosis) or Anaplasma platys (which infects platelets, causing cyclic thrombocytopenia). A. phagocytophilum is more clinically significant and is transmitted by Ixodes scapularis and Ixodes pacificus ticks, the same ticks that transmit Lyme disease. It causes fever, thrombocytopenia, and polyarthritis and is diagnosed by SNAP 4Dx Plus, blood smear, and PCR.

What are the symptoms of anaplasmosis in dogs?

Common symptoms include acute-onset high fever (103 to 106 degrees Fahrenheit), lethargy, anorexia, shifting leg lameness and joint swelling (polyarthritis), vomiting, and diarrhea. Laboratory findings include thrombocytopenia (low platelets) and mild anemia. In severe cases, bleeding signs such as nosebleeds, petechiae, or blood in stool may occur. The polyarthritis with joint pain and shifting lameness is a particularly characteristic feature of A. phagocytophilum infection.

How is anaplasmosis diagnosed in dogs?

The SNAP 4Dx Plus in-clinic test detects Anaplasma antibodies and is the standard first-line test; it also simultaneously tests for Lyme disease, Ehrlichia, and heartworm. A CBC showing thrombocytopenia supports the diagnosis. Blood smear examination may reveal morulae (purple inclusion bodies) inside neutrophils. PCR of whole blood is the most sensitive test during early acute infection. IFA serology confirming a fourfold titer rise between paired samples is the gold standard for retrospective confirmation.

What is the treatment for anaplasmosis in dogs?

Doxycycline 10 mg/kg once daily for 28 days is the standard treatment. Most dogs improve dramatically within 24 to 48 hours. Doxycycline should be given with a small amount of food to reduce the risk of esophageal irritation. A follow-up CBC 2 to 4 weeks after completing treatment confirms platelet count normalization. A positive SNAP Anaplasma result after treatment does not indicate treatment failure; it reflects residual antibodies that persist for months after the infection is cleared.

Can a dog get anaplasmosis and Lyme disease at the same time?

Yes. Anaplasma phagocytophilum and Borrelia burgdorferi (Lyme disease) are both transmitted by Ixodes scapularis and share the same geographic distribution in the northeastern and upper Midwest United States. A single tick bite can transmit both organisms simultaneously. Co-infected dogs may have more severe or atypical presentations. The SNAP 4Dx Plus tests for both simultaneously. Tick prevention with isoxazolines reduces the risk of both diseases at once.

Does a positive SNAP Anaplasma result after treatment mean the dog is still sick?

No. Antibodies to Anaplasma persist for months to over a year after successful doxycycline treatment. A positive SNAP at recheck does not indicate treatment failure or ongoing active infection. The correct way to assess treatment success is a follow-up CBC: platelet count normalization (above 150,000 to 200,000 per microliter) confirms that the infection has been eliminated. Dogs with normal platelets and no clinical signs after completing treatment are considered successfully treated, regardless of SNAP results.

How can I prevent anaplasmosis in my dog?

Consistent use of an effective tick prevention product is the most important preventive measure. Isoxazoline products (NexGard, Simparica, Bravecto, Credelio) kill Ixodes ticks before they can transmit Anaplasma and should be used year-round in endemic areas. Daily tick checks after outdoor activity, especially in wooded or grassy areas, allow prompt tick removal; since Anaplasma transmission requires 24 to 48 hours of tick attachment, removing ticks within this window substantially reduces infection risk. Annual SNAP 4Dx Plus screening at wellness visits allows early detection of subclinical exposure.

For more guides on keeping your dog healthy, browse all our Dog Health articles.

Explore Dog Health Articles